cbdMD Inc (YCBD)
0.8801
-0.05
(-5.38%)
USD |
NYAM |
May 02, 11:48
cbdMD Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.0003 |
June 30, 2023 | 0.0002 |
March 31, 2023 | 0.0003 |
December 31, 2022 | 0.0004 |
September 30, 2022 | 0.0003 |
June 30, 2022 | 0.0002 |
March 31, 2022 | 0.0008 |
December 31, 2021 | 0.0007 |
September 30, 2021 | 0.0006 |
June 30, 2021 | 0.0007 |
March 31, 2021 | 0.0192 |
December 31, 2020 | 0.0194 |
September 30, 2020 | 0.0191 |
June 30, 2020 | 0.0203 |
Date | Value |
---|---|
March 31, 2020 | 0.004 |
December 31, 2019 | 0.0083 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | -0.0508 |
December 31, 2018 | 0.0454 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.0232 |
December 31, 2017 | 0.027 |
September 30, 2017 | 0.0855 |
June 30, 2017 | 0.00 |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | 2.194 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.0203
Maximum
Jun 2020
0.005
Average
0.0006
Median
Sep 2021
Debt to Equity Ratio Benchmarks
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 15.10M |
Total Liabilities (Quarterly) | 8.058M |
Shareholders Equity (Quarterly) | 7.037M |
Current Ratio | 1.234 |
Net Debt Paydown Yield | 0.06% |